¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019³â ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019³â ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-22
±³À°ÀÏÀÚ : 2019-11-22
±³À°Àå¼Ò : Àá½Ç ·Ôµ¥È£ÅÚ Å©¸®½ºÅ»·ë  
±³À°ÁÖÁ¦ : 2019³â ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸ 
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540  
À̸ÞÀÏ : kalc@naver.com      
±³À°Á¾·ù : ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 25ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í »çÀüµî·Ï(Àü¹®ÀÇ): 5¸¸¿ø ÇöÀåµî·Ï(Àü¹®ÀÇ): 7¸¸¿ø ÇöÀåµî·Ï(Àü°øÀÇ/Çлý/ÀüÀÓÀÇ/°£È£»ç/±âŸ): 5¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 09:25~09:50 Multiplexed omics approach in lung cancer research  ±èÅÂÁ¤(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 09:50~10:15 Towards successful cancer vaccine development  ±èÁß±Ô(ÆèÅä¹ÙÀÌ¿À¸Þµå) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 10:15~10:40 Cell and gene therapy for lung cancer  Sam Janes(University College London Hospitals) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 09:00~09:25 Oncologic outcomes of segmentectomy in early lung cancer  ±èÈ«°ü(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 09:25~09:50 Application of navigation bronchoscopy in lung cancer surgery  ¹ÚÀαÔ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 09:50~10:15 Single Port Lung Cancer Surgery  ±èÇö±¸(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 10:15~10:40 Image-guided surgery in lung cancer  ÀÌ⿵(¿¬¼¼ÀÇ´ë) 
È޽Ġ11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 10:40~11:10 È޽Ġ () 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 11:10~11:50 Whole genomic landscape of pre-invasive lung cancer lesions  Sam Janes(University College London Hospitals) 
Åä·Ð 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 11:50~12:00 Q & A  Sam Janes(University College London Hospitals) 
½Ä»ç 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 12:00~12:40 Luncheon Symposium II.  °­ÁøÇü(°¡Å縯ÀÇ´ë) 
È޽Ġ11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 12:40~13:00 ÃÑȸ  () 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 13:00~13:20 Æó¾Ïº´±âÁ¶»ç»ç¾÷(KALC R)ÀÇ °æ°ú ¹× ¹ßÀü ¹æÇâ  ÃÖâ¹Î(¿ï»êÀÇ´ë) 
È޽Ġ11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 13:20~13:40   () 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 13:40~14:05 Overcoming Resistance to first-line osimertinib in EGFR-mutant lung cancer  ÀÌÀ±±Ô(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 14:05~14:30 Emerging therapies for Resistance of ALK-Targeted Therapies  À̽·æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 14:30~14:55 Resistance Mechanisms to BRAF/MEK inhibition in BRAF-mutant lung cancer  À±½Å±³(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2 14:55~15:20 Emerging Rare Targets beyond EGFR/ALK/ROS1/BRAF in Lung Cancer  ±èÀ¯Á¤(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 13:40~14:05 Lung cancer screening in Korea: Potential future directions  Àå½ÂÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 14:05~14:30 Lung cancer screening in Korea: Lessons the K-LUCAS  ±è¿­(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 14:30~14:55 Lung cancer screening with low-dose CT: What we have learned  ±¸Áø¸ð(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 3 14:55~15:20 Lung-RADS: All you need to know  ±èÇý¿µ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 2,3 15:20~15:40 History and current status of the new tobacco products  ±èÀ¯ÀÏ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 2,3 15:40~16:00 Safety assessment of the new tabacco products  ¹ÚÇýÁ¤(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 2,3 16:00~16:20 Regulatory strategies in perspective of population science for the new tobacco products  ±èÈñÁø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1 15:20~16:20 Oral Presentation III.  À̰DZ¹(±¹¸³¾Ï¼¾ÅÍ) 
È޽Ġ11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 16:20~16:50 È޽Ġ () 
Åä·Ð 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 16:50~17:20 Topic I. Local Treatment for Oligometastases  Á¶¼®±â(¼­¿ïÀÇ´ë) 
Åä·Ð 11-22 Àá½Ç ·Ôµ¥È£ÅÚ Crystal 1,2,3 17:20~17:50 Topic II. Harmonizing systemic therapy with local treatment for oligometastases  È«¹ÎÈñ(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019³â ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø ´ëÇÑû¼Ò³âÁ¤½ÅÀÇÇÐȸ û¼Ò³â Á¤½ÅÄ¡·á: ¿øÄ¢°ú ½ÇÁ¦ : 2019-11-22
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ(¸Á¸·ÀÇ ÃֽŠÁö°ß) : 2019-11-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
557 ºÎ»ê ´ëÇѺ´¸®ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ À¯¹æ ¹× ºñ´¢»ý½Ä±â°è º´¸®ÀÇ ÃÖ½ÅÁö°ß : 2018-09-04 0 908 2018-08-29
556 ¼­¿ï ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ ¿ù·ÊÁý´ãȸ : 2018-09-04 0 959 2018-08-29
555 ¼­¿ï Á¦37ȸ ´ëÇѹ̿ë¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-02 0 1,957 2018-08-29
554 ¼­¿ï Á¦ 4ȸ ´ëÇѰ˾ÈÇÐȸ ±¼Àý°Ë»ç¿Í ¾È°æó¹æ Workshop : 2018-09-30 0 1,024 2018-08-22
553 ºÎ»ê 2018³â ºÎ»ê¿ï»ê°æ³² ½Å°æ°úÁöȸ Ãß°èÇмú´ëȸ : 2018-09-29 0 1,146 2018-08-22
552 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À°(ÁßÀÌ¿°) : 2018-09-28 0 1,303 2018-08-22
551 ¼­¿ï ¿øÀڷº´¿ø Á¦38ȸ°³¿øÀÇ ¿¬¼ö°­ÁÂ(È£Èí±âÁúȯ) : 2018-09-20 0 2,295 2018-08-22
550 ´ë±¸ ÆÄƼ¸¶º´¿ø ´ë±¸°æºÏÇ÷¾×ÁöºÎÇÐȸ : 2018-09-19 0 914 2018-08-22
549 Ãæ³² ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 1. ÀÓ»óÁ¤½ÅÀÇÇÐ , 2. ¹Ýº¹Àû ÀÚÇØ ½Ãµµ û¼Ò³â¿¡ ´ëÇÑ ÀÌÇØ : 2018-09-18 0 5,056 2018-08-22
548 ÀüºÏ Á¦3Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2018-09-18 0 701 2018-08-22
547 ÃæºÏ ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus Conference(CEO±³À°) : 2018-09-17 0 1,387 2018-08-22
546 ºÎ»ê µ¿¾Æ´ëÇб³º´¿ø ´ëÇѼÒÈ­±âÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2018-09-17 0 1,614 2018-08-22
545 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø °³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ Áõ·Ê ´Ù½Ã º¸±â¿Í ´ÙÃÊÁ¡ Àΰø¼öÁ¤Ã¼ Ư°­ : 2018-09-16 0 1,949 2018-08-22
544 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø ECHO SEOUL 2018 : 2018-09-16 0 1,422 2018-08-22
543 ¼­¿ï 2018 ´ëÇÑÀ忬±¸ÇÐȸ ¿¬¼ö°­Á : 2018-09-16 0 795 2018-08-22
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷